1.1)华北理工大学研究生院,唐山 063200;2.2)唐山市人民医院肿瘤防治研究所中心实验室,唐山 063000;3.3)华北理工大学校医院,唐山 063200;4.4)华北理工大学生命科学学院,唐山 063200;5.5)唐山市人民医院神经外科,唐山 063000
1.1)Graduate School of North China University of Science and Technology, Tangshan 063200, China;2.2)Central Laboratory of Cancer Research Institute of Tangshan People's Hospital, Tangshan 063000, China;3.3)North China University of Science and Technology School Clinic, Tangshan 063200, China;4.4)School of Life Science,North China University of Science and Technology, Tangshan 063200, China;5.5)Department of Neurosurgery, Tangshan People's Hospital,Tangshan, 063000, China
乙型肝炎病毒x(Hepatitis B virus x, HBx)蛋白与乙型肝炎病毒(Hepatitis B Virus,HBV)相关性肝细胞癌(Hepatocellular Carcinoma,HCC)的发病机制有一定的联系。乙型肝炎病毒X在肝癌形成过程中表观遗传变异的机制仍不清楚。我们发现microRNA-200c(miR-200c)在表达乙型肝炎病毒的肝癌细胞中下调,并且它直接靶向DNA甲基转移酶3A(DNA methyltransferase 3A,DNMT3A)。此外,miR-200c和DNMT3A在乙型肝炎病毒诱导的肝癌组织中呈现反相关。乙型肝炎病毒诱导miR-200c下调,诱导DNMT3A表达上调,然后导致肝癌细胞中肿瘤相关基因的启动子超甲基化。 我们对乙型肝炎病毒诱导的肝癌的表观遗传学方面进行了进一步研究,并确定了一种基于miRNA的靶向治疗乙型肝炎病毒相关的肝癌的潜在方法。
The hepatitis B virus x (HBx) protein has been implicated in the pathogenesis of HBV-associated hepatocellular carcinoma (HCC). The mechanisms of HBx involved in epigenetic changes during hepatocarcinogenesis are still obscure. We report here that microRNA-200c (miR-200c) was downregulated in HBV-expressing HCC cells and it targeted DNMT3A directly.. In addition, an inverse correlation between miR-200c and DNA methyltransferase 3A (DNMT3A) was founded in HBV-induced HCC tissues. HBV-induced downregulation of miR-200c upregulated DNMT3A expression, and then resulted in promoter hypermethylation of tumor-related genes in HCC. Our data supplied an epigenetic insight into HBV-induced HCC and identified a potential miRNA-based targeted approach for treating HBV-related HCC.
张媛悦,王淑青,刘岩,刘艳坤,李玉辉,李玉凤.乙型肝炎病毒X蛋白通过靶向miR-200c诱导DNA异常甲基化[J].生物化学与生物物理进展,2020,47(10):1080-1089
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号